PJET yields 2000000.00% · ABBV yields 3.06%● Live data
📍 PJET pulled ahead of the other in Year 1
Combined, PJET + ABBV cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of PJET + ABBV for your $10,000?
Priority One Jets, Inc. operates as a full service aviation company that provides on demand air charter, jet charter membership cards, and aircraft sales for business aviation, leisure, and government travel. It offers jet sales and leasing services that include private jet leasing and sales, aircraft fractional ownership, and private jet acquisition pricing services; private jet services, including concierge services, private aircraft management and maintenance, private helicopter charter, flight monitoring and coordination, air cargo charter, and government travel services, as well as personal security, medical transport, and disasters evacuation services. The company also provides air cargo freight jet charters for freight forwarding; transportation of heavy and outsize pieces, construction equipment and machine parts, high value commodities and secure/point-to-point, aerospace equipment, peacekeeping support, and dangerous materials; and critical parcel delivery, secure aircraft loading and docking, and remote originations and destinations, as well as oil, automotive, and gas industry/equipment transportation. It offers charter services for various destinations that include New York City, Miami, Los Angeles, Las Vegas, London, Sydney, Bahamas, Monaco, Istanbul, and Ibiza. The company is based in New York, New York with additional locations in the Americas, Europe, and Asia.
Full PJET Calculator →AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Full ABBV Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.